Literature DB >> 10749783

Dose-dependent effects of endotoxin on human sleep.

J Mullington1, C Korth, D M Hermann, A Orth, C Galanos, F Holsboer, T Pollmächer.   

Abstract

The role of the central nervous system in the host response to infection and inflammation and modulation of these responses by the hypothalamic-pituitary-adrenal system are well established. In animals, activation of host defense mechanisms increases non-rapid eye movement (NREM) sleep amount and intensity, which, in turn, are thought to support host defense, or the body's ability to defend itself against challenges to its immune system. In humans, the evidence is conflicting. Therefore, we investigated the effects of three placebo-controlled doses of endotoxin on host response, including nocturnal sleep in healthy volunteers. Administered before nocturnal sleep onset, endotoxin dose dependently increased rectal temperature, heart rate, and the plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-1 receptor antagonist, IL-6, and cortisol. The lowest dose reliably increased circulating levels of cytokines and soluble cytokine receptors, but it did not affect rectal temperature, heart rate, or cortisol. This subtle host defense activation increased deep NREM sleep amount, often referred to as slow-wave sleep (stages 3 and 4), and intensity (delta power). Conversely, the highest dose of endotoxin disrupted sleep. Whereas it is well established that the endocrine and thermoregulatory systems are very sensitive to endotoxin, this study shows that human sleep-wake behavior is even more sensitive to activation of host defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749783     DOI: 10.1152/ajpregu.2000.278.4.R947

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  59 in total

1.  Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Authors:  Charles L Raison; David B Rye; Bobbi J Woolwine; Gerald J Vogt; Breanne M Bautista; James R Spivey; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2010-05-26       Impact factor: 13.382

Review 2.  Sleep disturbance, inflammation and depression risk in cancer survivors.

Authors:  Michael R Irwin; Richard E Olmstead; Patricia A Ganz; Reina Haque
Journal:  Brain Behav Immun       Date:  2012-05-24       Impact factor: 7.217

3.  Effects of sleep deprivation on measures of the febrile reaction and the recovery of somatovisceral functions and sleep in endotoxemia.

Authors:  K V Lapshina; I V Ekimova
Journal:  Neurosci Behav Physiol       Date:  2010-03-26

4.  FMRFamide signaling promotes stress-induced sleep in Drosophila.

Authors:  Olivia Lenz; Jianmei Xiong; Matthew D Nelson; David M Raizen; Julie A Williams
Journal:  Brain Behav Immun       Date:  2015-02-07       Impact factor: 7.217

5.  SLEEP AND CYTOKINES.

Authors:  James M Krueger; David M Rector; Lynn Churchill
Journal:  Sleep Med Clin       Date:  2007

Review 6.  Reciprocal regulation of the neural and innate immune systems.

Authors:  Michael R Irwin; Steven W Cole
Journal:  Nat Rev Immunol       Date:  2011-08-05       Impact factor: 53.106

Review 7.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

Review 8.  Inflammation at the intersection of behavior and somatic symptoms.

Authors:  Michael R Irwin
Journal:  Psychiatr Clin North Am       Date:  2011-09

Review 9.  Timing Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer.

Authors:  Kimberly K Truong; Michael T Lam; Michael A Grandner; Catherine S Sassoon; Atul Malhotra
Journal:  Ann Am Thorac Soc       Date:  2016-07

10.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.